http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-3036553-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-44 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-35 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 |
| filingDate | 1980-09-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5a5320f1f05dc76006411c88d7b144d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d93dd7a3a9b133d4ac21bb67aedcc014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e912a124707982c49a6458a5dfbddd6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a43b99d42d2cdba5f408dea489eefb5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89252cd215bb4cd75e7a360e18427970 |
| publicationDate | 1981-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | DE-3036553-A1 |
| titleOfInvention | SUBSTITUTED 2- (PYRIDYL-CYCLOPROPYL) CHROMONES, METHOD FOR THE PRODUCTION THEREOF AND PHARMACEUTICAL AGENTS CONTAINING THE SAME |
| abstract | 2-Trans-(2-(2-pyridyl)-cyclopropyl) -chromone-6-carboxylic acid derivs and their salts of formula 2-Trans (2-(methyl-pyrid- 2-yl) -cyclopropyl) -3-R2-(O)n-6-R100C-chromone, (I), are new. In (I) n is 0 or 1; R1 is H or 1-4C alkyl (opt. substd. by -NR3R4); R3,R4 independently are H or 1-2C alkyl to give a basic ester radical; R2 is 2-3C alkyl or allyl and the methyl group on the pyridyl ring is in position 5 or 6). Cpds. are antiallergics, used to treat bronchial asthma, allergic rhinitis, hay fever, urticaria, dermatoses etc., which are active by oral admin. They may be administered orally or parenterally in daily doses of 0.25-15mg/kg, by inhalation in daily doses of 0.25- 100 mg., esp. 0.5-25 mg. or by topical application. Some of the cpds. also have antiulcer activity. |
| priorityDate | 1978-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 75.